- Home
- MDAI vs KRRO Comparison
MDAI vs KRRO Comparison
Compare MDAI & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- KRRO
- Stock Information
- Founded
- MDAI 2013
- KRRO 2014
- Country
- MDAI United States
- KRRO United States
- Employees
- MDAI N/A
- KRRO N/A
- Industry
- MDAI Medical/Dental Instruments
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- MDAI Health Care
- KRRO Health Care
- Exchange
- MDAI Nasdaq
- KRRO Nasdaq
- Market Cap
- MDAI 55.9M
- KRRO 58.6M
- IPO Year
- MDAI N/A
- KRRO 2019
- Fundamental
- Price
- MDAI $1.33
- KRRO $6.13
- Analyst Decision
- MDAI Strong Buy
- KRRO Buy
- Analyst Count
- MDAI 2
- KRRO 10
- Target Price
- MDAI $3.25
- KRRO $74.17
- AVG Volume (30 Days)
- MDAI 554.9K
- KRRO 957.3K
- Earning Date
- MDAI 11-11-2025
- KRRO 11-12-2025
- Dividend Yield
- MDAI N/A
- KRRO N/A
- EPS Growth
- MDAI N/A
- KRRO N/A
- EPS
- MDAI N/A
- KRRO N/A
- Revenue
- MDAI $23,168,000.00
- KRRO $7,371,000.00
- Revenue This Year
- MDAI N/A
- KRRO $116.91
- Revenue Next Year
- MDAI $60.05
- KRRO N/A
- P/E Ratio
- MDAI N/A
- KRRO N/A
- Revenue Growth
- MDAI N/A
- KRRO N/A
- 52 Week Low
- MDAI $1.01
- KRRO $5.70
- 52 Week High
- MDAI $3.25
- KRRO $56.69
- Technical
- Relative Strength Index (RSI)
- MDAI 24.84
- KRRO 21.04
- Support Level
- MDAI $1.38
- KRRO $5.82
- Resistance Level
- MDAI $1.55
- KRRO $6.59
- Average True Range (ATR)
- MDAI 0.13
- KRRO 2.04
- MACD
- MDAI -0.05
- KRRO -2.55
- Stochastic Oscillator
- MDAI 1.37
- KRRO 1.19
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.